APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Indoleamine 2,3 Dioxygenase 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Indoleamine 2,3 Dioxygenase 1 Industry Growth and Trends Forecast to 2032

Report ID 174002450119 December 2025107 pages

Choose your research edition.

Industry ResearchIndoleamine 2,3 Dioxygenase 1 Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Indoleamine 2,3 Dioxygenase 1 Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Indoleamine 2,3 Dioxygenase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indoleamine 2,3 Dioxygenase 1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Indoleamine 2,3 Dioxygenase 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Indoleamine 2,3 Dioxygenase 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indoleamine 2,3 Dioxygenase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Indoleamine 2,3 Dioxygenase 1 include F. Hoffmann-La Roche Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Regen BioPharma Inc, Redx Pharma Plc, NewLink Genetics Corp, Netherlands Translational Research Center BV, Kyowa Hakko Kirin and IO Biotech ApS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Indoleamine 2,3 Dioxygenase 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Indoleamine 2,3 Dioxygenase 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Indoleamine 2,3 Dioxygenase 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Indoleamine 2,3 Dioxygenase 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Indoleamine 2,3 Dioxygenase 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Indoleamine 2,3 Dioxygenase 1 Market by Company

F. Hoffmann-La Roche Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Regen BioPharma Inc

Redx Pharma Plc

NewLink Genetics Corp

Netherlands Translational Research Center BV

Kyowa Hakko Kirin

IO Biotech ApS

Incyte Corp

Globavir Biosciences Inc

Genentech Inc

Ensemble Therapeutics Corp

BirchBioMed Inc

Indoleamine 2,3 Dioxygenase 1 Segment by Type

BMS-986205

Dcellvax

F-001287

Galanal

Epacadostat

Others

Indoleamine 2,3 Dioxygenase 1 Segment by Application

Gastric Cancer

Aolpecia

Glioma

Cervical Cancer

Others

Indoleamine 2,3 Dioxygenase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indoleamine 2,3 Dioxygenase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indoleamine 2,3 Dioxygenase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indoleamine 2,3 Dioxygenase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Indoleamine 2,3 Dioxygenase 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Indoleamine 2,3 Dioxygenase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of BMS-986205 Table 2. Major Company of Dcellvax Table 3. Major Company of F-001287 Table 4. Major Company of Galanal Table 5. Major Company of Epacadostat Table 6. Major Company of Others Table 7. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 9. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type (2021-2026) Table 10. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (US$ Million) Table 11. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type (2021-2026) Table 12. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2026) & (US$/Unit) Table 13. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 14. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type (2027-2032) Table 15. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (US$ Million) Table 16. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type (2027-2032) Table 17. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2027-2032) & (US$/Unit) Table 18. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 19. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 21. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 25. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (US$ Million) Table 28. Indoleamine 2,3 Dioxygenase 1 Industry Trends Table 29. Indoleamine 2,3 Dioxygenase 1 Industry Drivers Table 30. Indoleamine 2,3 Dioxygenase 1 Industry Opportunities and Challenges Table 31. Indoleamine 2,3 Dioxygenase 1 Industry Restraints Table 32. Global Indoleamine 2,3 Dioxygenase 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Company (2021-2026) Table 34. Global Indoleamine 2,3 Dioxygenase 1 Sales by Company (2021-2026) & (K Units) Table 35. Global Indoleamine 2,3 Dioxygenase 1 Sales Share by Company (2021-2026) Table 36. Global Indoleamine 2,3 Dioxygenase 1 Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Indoleamine 2,3 Dioxygenase 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Indoleamine 2,3 Dioxygenase 1 Major Company Production Sites and Headquarters Table 39. Global Indoleamine 2,3 Dioxygenase 1 Company, Product Type & Application Table 40. Global Indoleamine 2,3 Dioxygenase 1 Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Indoleamine 2,3 Dioxygenase 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Indoleamine 2,3 Dioxygenase 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026) & (K Units) Table 45. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Region (2021-2026) Table 46. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026) & (US$ Million) Table 47. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Region (2021-2026) Table 48. Global Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2027-2032) & (K Units) Table 50. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Region (2027-2032) Table 51. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2027-2032) & (US$ Million) Table 52. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Region (2027-2032) Table 53. Global Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 56. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application (2021-2026) Table 57. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (US$ Million) Table 58. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application (2021-2026) Table 59. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2026) & (US$/Unit) Table 60. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 61. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application (2027-2032) Table 62. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (US$ Million) Table 63. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application (2027-2032) Table 64. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2027-2032) & (US$/Unit) Table 65. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 66. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 68. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 72. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (US$ Million) Table 75. F. Hoffmann-La Roche Ltd Company Information Table 76. F. Hoffmann-La Roche Ltd Business Overview Table 77. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 79. F. Hoffmann-La Roche Ltd Recent Development Table 80. Pfizer Inc Company Information Table 81. Pfizer Inc Business Overview Table 82. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 84. Pfizer Inc Recent Development Table 85. Bristol-Myers Squibb Company Company Information Table 86. Bristol-Myers Squibb Company Business Overview Table 87. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 89. Bristol-Myers Squibb Company Recent Development Table 90. Regen BioPharma Inc Company Information Table 91. Regen BioPharma Inc Business Overview Table 92. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 94. Regen BioPharma Inc Recent Development Table 95. Redx Pharma Plc Company Information Table 96. Redx Pharma Plc Business Overview Table 97. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 99. Redx Pharma Plc Recent Development Table 100. NewLink Genetics Corp Company Information Table 101. NewLink Genetics Corp Business Overview Table 102. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 104. NewLink Genetics Corp Recent Development Table 105. Netherlands Translational Research Center BV Company Information Table 106. Netherlands Translational Research Center BV Business Overview Table 107. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 109. Netherlands Translational Research Center BV Recent Development Table 110. Kyowa Hakko Kirin Company Information Table 111. Kyowa Hakko Kirin Business Overview Table 112. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 114. Kyowa Hakko Kirin Recent Development Table 115. IO Biotech ApS Company Information Table 116. IO Biotech ApS Business Overview Table 117. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 119. IO Biotech ApS Recent Development Table 120. Incyte Corp Company Information Table 121. Incyte Corp Business Overview Table 122. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 124. Incyte Corp Recent Development Table 125. Globavir Biosciences Inc Company Information Table 126. Globavir Biosciences Inc Business Overview Table 127. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 129. Globavir Biosciences Inc Recent Development Table 130. Genentech Inc Company Information Table 131. Genentech Inc Business Overview Table 132. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 134. Genentech Inc Recent Development Table 135. Ensemble Therapeutics Corp Company Information Table 136. Ensemble Therapeutics Corp Business Overview Table 137. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 139. Ensemble Therapeutics Corp Recent Development Table 140. BirchBioMed Inc Company Information Table 141. BirchBioMed Inc Business Overview Table 142. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 144. BirchBioMed Inc Recent Development Table 145. North America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 147. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2026) Table 148. North America Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 149. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share Forecast by Country (2027-2032) Table 150. North America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. North America Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026) & (US$ Million) Table 152. North America Indoleamine 2,3 Dioxygenase 1 Market Share by Country (2021-2026) Table 153. North America Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. North America Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Country (2027-2032) Table 155. Europe Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 157. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2026) Table 158. Europe Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 159. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share Forecast by Country (2027-2032) Table 160. Europe Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026) & (US$ Million) Table 162. Europe Indoleamine 2,3 Dioxygenase 1 Market Share by Country (2021-2026) Table 163. Europe Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Europe Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Country (2027-2032) Table 165. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 167. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2026) Table 168. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 169. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share Forecast by Country (2027-2032) Table 170. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026) & (US$ Million) Table 172. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Share by Country (2021-2026) Table 173. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Country (2027-2032) Table 175. Latin America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 176. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 177. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2026) Table 178. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 179. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share Forecast by Country (2027-2032) Table 180. Latin America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Latin America Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026) & (US$ Million) Table 182. Latin America Indoleamine 2,3 Dioxygenase 1 Market Share by Country (2021-2026) Table 183. Latin America Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Latin America Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Country (2027-2032) Table 185. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 186. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 187. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2021-2026) Table 188. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032) & (K Units) Table 189. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share Forecast by Country (2027-2032) Table 190. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026) & (US$ Million) Table 192. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Share by Country (2021-2026) Table 193. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Share Forecast by Country (2027-2032) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Indoleamine 2,3 Dioxygenase 1 Distributors List Table 198. Indoleamine 2,3 Dioxygenase 1 Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Indoleamine 2,3 Dioxygenase 1 Image Figure 2. Global Indoleamine 2,3 Dioxygenase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indoleamine 2,3 Dioxygenase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Indoleamine 2,3 Dioxygenase 1 Sales (2021-2032) & (K Units) Figure 5. BMS-986205 Image Figure 6. Global BMS-986205 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Dcellvax Image Figure 8. Global Dcellvax Sales YoY Growth (2021-2032) & (K Units) Figure 9. F-001287 Image Figure 10. Global F-001287 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Galanal Image Figure 12. Global Galanal Sales YoY Growth (2021-2032) & (K Units) Figure 13. Epacadostat Image Figure 14. Global Epacadostat Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Indoleamine 2,3 Dioxygenase 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Indoleamine 2,3 Dioxygenase 1 Market Share by Type 2025 VS 2032 Figure 19. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2025 Figure 20. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2025 Figure 21. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2025 Figure 22. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2025 Figure 25. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Indoleamine 2,3 Dioxygenase 1 Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Gastric Cancer Image Figure 32. Global Gastric Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Aolpecia Image Figure 34. Global Aolpecia Sales YoY Growth (2021-2032) & (K Units) Figure 35. Glioma Image Figure 36. Global Glioma Sales YoY Growth (2021-2032) & (K Units) Figure 37. Cervical Cancer Image Figure 38. Global Cervical Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global Indoleamine 2,3 Dioxygenase 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Indoleamine 2,3 Dioxygenase 1 Market Share by Application 2025 VS 2032 Figure 43. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2025 Figure 44. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2025 Figure 45. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2025 Figure 46. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2025 Figure 49. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share in Value by Application in 2025 Figure 53. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America Indoleamine 2,3 Dioxygenase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Indoleamine 2,3 Dioxygenase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Indoleamine 2,3 Dioxygenase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe Indoleamine 2,3 Dioxygenase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Indoleamine 2,3 Dioxygenase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Indoleamine 2,3 Dioxygenase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America Indoleamine 2,3 Dioxygenase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Indoleamine 2,3 Dioxygenase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Indoleamine 2,3 Dioxygenase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Indoleamine 2,3 Dioxygenase 1 Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Indoleamine 2,3 Dioxygenase 1 Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • BMS-986205
  • Dcellvax
  • F-001287
  • Galanal
  • Epacadostat
  • Others
Applications
  • Gastric Cancer
  • Aolpecia
  • Glioma
  • Cervical Cancer
  • Others
Companies covered
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Regen BioPharma Inc
  • Redx Pharma Plc
  • NewLink Genetics Corp
  • Netherlands Translational Research Center BV
  • Kyowa Hakko Kirin
  • IO Biotech ApS
  • Incyte Corp
  • Globavir Biosciences Inc
  • Genentech Inc
  • Ensemble Therapeutics Corp
  • BirchBioMed Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Indoleamine 2,3 Dioxygenase 1 Market by Type
  6. 1.3.1 BMS-986205
  7. 1.3.2 Dcellvax
  8. 1.3.3 F-001287
  9. 1.3.4 Galanal
  10. 1.3.5 Epacadostat
  11. 1.3.6 Others
  12. 1.4 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Type
  13. 1.4.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Indoleamine 2,3 Dioxygenase 1 Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Indoleamine 2,3 Dioxygenase 1 Industry Trends
  2. 2.2 Indoleamine 2,3 Dioxygenase 1 Industry Drivers
  3. 2.3 Indoleamine 2,3 Dioxygenase 1 Industry Opportunities and Challenges
  4. 2.4 Indoleamine 2,3 Dioxygenase 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Indoleamine 2,3 Dioxygenase 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Indoleamine 2,3 Dioxygenase 1 Price (2021-2026)
  4. 3.4 Global Indoleamine 2,3 Dioxygenase 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Indoleamine 2,3 Dioxygenase 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Indoleamine 2,3 Dioxygenase 1 Company, Product Type & Application
  7. 3.7 Global Indoleamine 2,3 Dioxygenase 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Indoleamine 2,3 Dioxygenase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Indoleamine 2,3 Dioxygenase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Indoleamine 2,3 Dioxygenase 1 Tier 1, Tier 2, and Tier 3
4 Indoleamine 2,3 Dioxygenase 1 Regional Status and Outlook
  1. 4.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Indoleamine 2,3 Dioxygenase 1 Historic Market Size by Region
  3. 4.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Region
  7. 4.3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Indoleamine 2,3 Dioxygenase 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Indoleamine 2,3 Dioxygenase 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Indoleamine 2,3 Dioxygenase 1 by Application
  1. 5.1 Indoleamine 2,3 Dioxygenase 1 Market by Application
  2. 5.1.1 Gastric Cancer
  3. 5.1.2 Aolpecia
  4. 5.1.3 Glioma
  5. 5.1.4 Cervical Cancer
  6. 5.1.5 Others
  7. 5.2 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Application
  8. 5.2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Indoleamine 2,3 Dioxygenase 1 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Indoleamine 2,3 Dioxygenase 1 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 F. Hoffmann-La Roche Ltd
  2. 6.1.1 F. Hoffmann-La Roche Ltd Company Information
  3. 6.1.2 F. Hoffmann-La Roche Ltd Business Overview
  4. 6.1.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  6. 6.1.5 F. Hoffmann-La Roche Ltd Recent Developments
  7. 6.2 Pfizer Inc
  8. 6.2.1 Pfizer Inc Company Information
  9. 6.2.2 Pfizer Inc Business Overview
  10. 6.2.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  12. 6.2.5 Pfizer Inc Recent Developments
  13. 6.3 Bristol-Myers Squibb Company
  14. 6.3.1 Bristol-Myers Squibb Company Company Information
  15. 6.3.2 Bristol-Myers Squibb Company Business Overview
  16. 6.3.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 6.4 Regen BioPharma Inc
  20. 6.4.1 Regen BioPharma Inc Company Information
  21. 6.4.2 Regen BioPharma Inc Business Overview
  22. 6.4.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  24. 6.4.5 Regen BioPharma Inc Recent Developments
  25. 6.5 Redx Pharma Plc
  26. 6.5.1 Redx Pharma Plc Company Information
  27. 6.5.2 Redx Pharma Plc Business Overview
  28. 6.5.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  30. 6.5.5 Redx Pharma Plc Recent Developments
  31. 6.6 NewLink Genetics Corp
  32. 6.6.1 NewLink Genetics Corp Company Information
  33. 6.6.2 NewLink Genetics Corp Business Overview
  34. 6.6.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  36. 6.6.5 NewLink Genetics Corp Recent Developments
  37. 6.7 Netherlands Translational Research Center BV
  38. 6.7.1 Netherlands Translational Research Center BV Company Information
  39. 6.7.2 Netherlands Translational Research Center BV Business Overview
  40. 6.7.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  42. 6.7.5 Netherlands Translational Research Center BV Recent Developments
  43. 6.8 Kyowa Hakko Kirin
  44. 6.8.1 Kyowa Hakko Kirin Company Information
  45. 6.8.2 Kyowa Hakko Kirin Business Overview
  46. 6.8.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  48. 6.8.5 Kyowa Hakko Kirin Recent Developments
  49. 6.9 IO Biotech ApS
  50. 6.9.1 IO Biotech ApS Company Information
  51. 6.9.2 IO Biotech ApS Business Overview
  52. 6.9.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  54. 6.9.5 IO Biotech ApS Recent Developments
  55. 6.10 Incyte Corp
  56. 6.10.1 Incyte Corp Company Information
  57. 6.10.2 Incyte Corp Business Overview
  58. 6.10.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  60. 6.10.5 Incyte Corp Recent Developments
  61. 6.11 Globavir Biosciences Inc
  62. 6.11.1 Globavir Biosciences Inc Company Information
  63. 6.11.2 Globavir Biosciences Inc Business Overview
  64. 6.11.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  66. 6.11.5 Globavir Biosciences Inc Recent Developments
  67. 6.12 Genentech Inc
  68. 6.12.1 Genentech Inc Company Information
  69. 6.12.2 Genentech Inc Business Overview
  70. 6.12.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  72. 6.12.5 Genentech Inc Recent Developments
  73. 6.13 Ensemble Therapeutics Corp
  74. 6.13.1 Ensemble Therapeutics Corp Company Information
  75. 6.13.2 Ensemble Therapeutics Corp Business Overview
  76. 6.13.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  78. 6.13.5 Ensemble Therapeutics Corp Recent Developments
  79. 6.14 BirchBioMed Inc
  80. 6.14.1 BirchBioMed Inc Company Information
  81. 6.14.2 BirchBioMed Inc Business Overview
  82. 6.14.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  84. 6.14.5 BirchBioMed Inc Recent Developments
7 North America by Country
  1. 7.1 North America Indoleamine 2,3 Dioxygenase 1 Sales by Country
  2. 7.1.1 North America Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  6. 7.2.1 North America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country
  2. 8.1.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  6. 8.2.1 Europe Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country
  2. 9.1.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Indoleamine 2,3 Dioxygenase 1 Sales by Country
  2. 10.1.1 South America Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  6. 10.2.1 South America Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country
  2. 11.1.1 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Indoleamine 2,3 Dioxygenase 1 Value Chain Analysis
  2. 12.1.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Indoleamine 2,3 Dioxygenase 1 Production Mode & Process
  7. 12.2 Indoleamine 2,3 Dioxygenase 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Indoleamine 2,3 Dioxygenase 1 Distributors
  10. 12.2.3 Indoleamine 2,3 Dioxygenase 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst